SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

During the Trading Day
8.86 -0.09 / -1.01%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.86 0.00 / 0.00%
 
Volume: 3.7K
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$448.0M

Company Description

SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company with a product portfolio of therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders. The company operates its business through two segments: China and Rest of the World including United States. Its ZADAXIN product is approved in over 30 countries and used for the treatment of hepatitis B (HBV), hepatitis C (HCV), as a vaccine adjuvant, and certain cancers. SciClone Pharmaceuticals was founded in 1990 and is headquartered in Foster City, CA.

Contact Information

SciClone Pharmaceuticals, Inc.
950 Tower Lane
Foster City California 94404-2125
P:(650) 358-3456
Investor Relations:
(650) 358-1447

Employees

Shareholders

Other institutional41.43%
Mutual fund holders31.17%
Individual stakeholders15.62%

Top Executives

Friedhelm BlobelPresident, Chief Executive Officer & Director
Wai-Shun Wilson CheungChief Financial Officer & Senior Vice President
Robert S. KingVice President-Product Development & Manufacturing
Lan XieChief Financial Officer-China Operations
Hong ZhaoChief Executive Officer-China Operations

To view my watchlist

Not a member yet?

Sign up now for a free account